XHE
State Street SPDR S&P Health Care Equipment ETF
SPDR S&P Health Care Equipment ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Health Care Equipment Select Industry Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 163.6 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | Jan 26, 2011 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| ATRICURE INC | 2.1 % |
| GLAUKOS CORP | 2.1 % |
| DENTSPLY SIRONA, INC. | 2.1 % |
| INTEGER HOLDINGS CORPORATION | 2.1 % |
| ENOVIS CORPORATION | 2.1 % |
| BUTTERFLY NETWORK, INC. CLASS A | 2.1 % |
| NEOGEN CORP | 2.1 % |
| BAXTER INTERNATIONAL INC | 2.0 % |
| CONMED CORP | 2.0 % |
| MERIT MEDICAL SYSTEMS INC | 2.0 % |
Constituent Breakdown
| Number of holdings | 64 |
| Herfindahl-Hirschman Index | 159 |
| Wgt avg mkt cap (mns) | $17,381 |
| Large cap (>$10bn) | 33.2% |
| Mid cap ($2-10bn) | 31.2% |
| Small cap (<$2bn) | 31.5% |
| Developed mkts. | 96.0% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 89.6 % |
 |
IRELAND | 3.4 % |
 |
BRITAIN | 3.0 % |
Historical Performance
Standardized Performance (as of 07/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 1.5% | 17.5% | 2.5% | -3.1% | -7.2% | 6.0% | -- | 8.5% |
| Dividend Yield | 0.0% | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | -- | 0.9% |
| Total Returns | 1.5% | 17.6% | 2.5% | -3.1% | -7.1% | 6.1% | -- | 9.4% | Ann. Volatility | 24.6% | 22.7% | 22.5% | 22.4% | 24.8% | 23.1% | -- | 21.3% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.85 | 23% |
| MSCI EAFE | 0.70 | 23% |
| MSCI Emg Mkts | 0.25 | 7% |
Liquidity Measures
| Avg. volume (000) | 24 |
| ADV traded (mns) | $2 |
| Turnover | 1.4% |
| Avg. Bid/Ask (% of price) | 0.21% |
Technical Indicators
| 30d moving avg. (EMA) | $86.41 |
| Relative strength (RSI) | 58 |
| MACD/Signal | 1.34/1.19 |
| Bollinger Bands (Upper/Lower) | $90.86/$84.38 |
| Short interest (% of AUM) | 27.4% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. XHE |
Expenses vs. XHE |
ALTAR Score™ vs. XHE |
|---|---|---|---|---|
| IHI | iShares U.S. Medical Devices ETF | 36.1% | +5 bp | +1.7% |
| MDEV | First Trust Indxx Medical Devices ETF | 35.8% | +35 bp | +1.5% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 27.0% | +33 bp | -1.5% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 22.6% | +5 bp | +3.0% |
| FXH | First Trust Health Care AlphaDEX Fund | 19.4% | +27 bp | +1.5% |
| HEAL | Global X HealthTech ETF | 18.7% | +15 bp | -4.1% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 18.3% | -6 bp | -1.2% |
| FDHT | Fidelity Digital Health ETF | 14.8% | +4 bp | -1.2% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 14.2% | +30 bp | -2.5% |
| FHLC | Fidelity MSCI Health Care Index ETF | 14.1% | -27 bp | +2.0% |
Risk and Returns: XHE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 8/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.5%
ALTAR SCORE™
19th
PERCENTILE
AVOID
ETFRC RATING
There are 1,401 funds in the US Equity category with an average
ALTAR Score™ of 5.2% and a standard deviation
of 2.0%. XHE's ALTAR Score™ is approximately -0.9 standard
deviations above the category average. This places XHE in the 19th percentile
among funds in the category.
Sell-Side Consensus
$104.69
PRICE TARGET
+13.6%
UPSIDE